Clinical trial
Calcitriol in Preventing Prostate Cancer in Patients With Prostatic…
NCT00118066 · Rutgers, The State University of New Jersey, Other · Terminated
Key facts
| NCT number | NCT00118066 |
|---|---|
| Title | Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia |
| Official title | A Randomized Phase II Trial Of Calcitriol In Patients With Prostatic Intraepithelial Neoplasia |
| Lead sponsor | Rutgers, The State University of New Jersey, Other |
| Collaborators | National Cancer Institute (NCI) NIH Rutgers Cancer Institute of New Jersey |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Precancerous/Nonmalignant Condition, Prostate Cancer |
| Intervention type | Dietary Supplement, Procedure |
| Interventions | calcitriol, observation |
| Enrollment | 12 |
| Start date | May 1, 2004 |
| Primary completion | Jun 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | Jul 11, 2005 |
| Last update posted | May 27, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: